The US Food and Drug Administration has approved Cyclopharm’s lung imagining technology Technegas, opening up a US$180 million market that has the potential to quadruple the size of Cyclopharm’s existing Pulmonary Embolism (PE) market. Technegas is an ultra-fine dispersion of the radiopharmaceutical Technetium-99m within a gas used in diagnostic functional lung imaging in 64 countries…
The UK Ministry of Defence has awarded £3.95 billion of funding to BAE Systems for the next phase of the UK’s next-generation nuclear-powered attack submarine programme, the SSN-AUKUS. SSN-AUKUS will be the largest, most powerful and advanced attack submarines the Royal Navy has ever operated, and will eventually replace the Astute class, which BAE Systems…
What were the five biggest stories of the week? Here’s what visitors to this site were reading. 5) Carbon Revolution attracts top global automotive directors Carbon fibre road wheel manufacturer Carbon Revolution has attracted a swag of leading automotive figures to join its executive team as the company moves towards a US stock exchange listing for…
